Grip Molecular Technologies Inc.
Saint Paul, MN
- UEI
- NXXSC2FSQCS6
- CAGE
- 8HYN0
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1000 Westgate Dr #122, St Paul, MN 55114, USA
- Website
- gripmolecular.com
- Founded
- 2019
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Research and development of ultra-sensitive PON detection of sars-COV-2 and influenza a antigens using graphene… | Office of the Assistant Secretary for Preparedness and Response | $354,267 |
About Grip Molecular Technologies Inc.
Grip Molecular Technologies Inc. is a biotechnology company that specializes in developing at-home medical diagnostics using next-generation graphene biosensors to provide lab-grade diagnostic results without the need for centralized laboratories. It is registered as a corporate entity and self-certified small disadvantaged business.
Grip Molecular Technologies Inc. has provided research and development services through a prime federal contract award from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The $354,267.22 firm fixed price definitive contract involved research and development of ultra-sensitive photonic integrated circuit detection of Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A antigens using graphene biosensors to support home-based diagnostics for acute SARS-CoV-2 infection. The performance took place in St. Paul, Minnesota over a period of one year from July 2022 through October 2023.
Grip Molecular Technologies Inc. has also provided services through sub-federal grant awards from the Atlanta Center for Microsystems Engineered Point-of-Care Technologies (ACME POCT) program, where Emory University was the prime grantee. The description of the sub-award indicates that the work involved microsystems engineered point-of-care technologies, which aligns with Grip Molecular Technologies Inc.'s focus on at-home medical diagnostics using advanced biosensor technology.
Quick answers
What is Grip Molecular Technologies Inc.'s UEI?
Grip Molecular Technologies Inc.'s Unique Entity ID (UEI) in SAM.gov is NXXSC2FSQCS6.
What is Grip Molecular Technologies Inc.'s CAGE code?
Grip Molecular Technologies Inc.'s CAGE code is 8HYN0.
What is Grip Molecular Technologies Inc.'s primary NAICS code?
Grip Molecular Technologies Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Grip Molecular Technologies Inc. located?
Grip Molecular Technologies Inc.'s physical address in SAM.gov is 1000 Westgate Dr #122, St Paul, MN 55114, USA.
Is Grip Molecular Technologies Inc. registered in SAM.gov?
Yes. Grip Molecular Technologies Inc.'s SAM.gov registration is active through June 15, 2027.
What is Grip Molecular Technologies Inc.'s most recent federal award?
Grip Molecular Technologies Inc.'s most recent federal contract award is Research and development of ultra-sensitive PON detection of sars-COV-2 and influenza a antigens using graphene… (75A50122C00039), from Office of the Assistant Secretary for Preparedness and Response, on July 28, 2022.
On GovTribe
See Grip Molecular Technologies Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors